Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Protopic for severe atopic dermatitis launched in U.S.

Feb. 20, 2001

Phase II trial establishes safety and optimal dose of PVAC psoriasis treatment

Feb. 19, 2001

Switch Biotech acquires delivery system for skin wounds

Feb. 15, 2001

In vitro study provides support for development of CS-891 as Rx for alopecia

Feb. 9, 2001

Phenyl ureas for the treatment of chemokine-mediated diseases

Feb. 8, 2001

Bridge Pharma/Immune Network alliance selects candidate for atopic dermatitis

Feb. 8, 2001

Vasogen prepares Canadian trial of VAS-972 for psoriasis

Feb. 2, 2001

IDEC-131 commences phase II trial for psoriasis

Jan. 30, 2001

Isotechnika's ISAtx-247 to be developed for third indication: psoriasis

Jan. 26, 2001

Chemokine receptor antagonists designed at the former SmithKline Beecham

Jan. 24, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...